Enhancing Delivery of Problem Solving Therapy using SmartPhone Technology

使用智能手机技术加强问题解决治疗的实施

基本信息

项目摘要

DESCRIPTION (provided by applicant): Access and engagement in evidence-based psychotherapies for Veterans are high priorities for the Veterans Health Administration (VHA), especially the Office of Rural Health (ORH) and the office of Mental Health Services (MHS). SmartPhone applications are an emerging technology with a vast potential to extend the reach of traditional in-person psychotherapy by allowing increased digital access to providers and self- management tools. Due to the relatively recent development of this technology, there are no data on the effectiveness of SmartPhone-delivered psychotherapy. Preliminary data on acceptability and satisfaction are promising, suggesting a need for further research. The National Center for PTSD in collaboration with the National Center for Telehealth & Technology (T2) recently completed the development of an app called Moving Forward, a Veteran-friendly adaptation of Problem Solving Therapy (PST), an evidence based therapy available through Primary Care Integration Clinics (PC-MHI). In partnership with MHS, this proposed pilot project will gather preliminary data on the effectiveness and acceptability of Moving Forward and provide timely feedback to the app creators. Participants will include 40 Veterans diagnosed with an anxiety or mood disorder interested in obtaining mental health treatment in PC-MHI. Participants will be randomly assigned to receive 6 sessions of either PST augmented by the Moving Forward app or 6 session of PST alone. Participants will complete assessments at baseline, 6 weeks and 12 weeks. We propose 3 specific hypotheses. In hypothesis 1, we predict an effect size e 0.3 will be observed when comparing scores on the PSSU (homework completion), and CSQ8 (satisfaction) at 6 and 12 weeks for patients randomized to PST plus the Moving Forward app compared to patients randomized to PST alone. In hypothesis 2, we predict an effect size e 0.3 will be observed when comparing change scores on the SPSI (problem solving style) at 6 and 12 weeks for patients randomized to PST plus the Moving Forward app compared to patients randomized to PST alone. In hypothesis 3, we predict an effect size e 0.3 will be observed when comparing change scores on the DASS composite score (depression, anxiety and stress) and SF-12 (health-related quality of life) at 6 and 12 weeks for patients randomized to PST plus the Moving Forward app compared to patients randomized to PST alone. Key informant interviews will provide qualitative feedback on the Moving Forward app which we will share with our partners at MHS. The proposed project is important to the VA mission to improve access for all Veterans particularly those who face barriers to engagement in traditional face-to-face treatment. The proposed research addresses one of three primary focus areas of the Office of Research and Development (Access), two of HSR&D's research priorities (Access/Rural Health and Mental Health), and three of Secretary Shinseki's Transformational Initiatives for the 21st Century including improving: 1) access to care, 2) mental health, and 3) patient-centeredness. This proposed work is innovative as it focuses on a rapidly emerging mobile technology that has great potential to improve access and engagement in mental health service delivery. To date, there have been no randomized effectiveness trials that have examined SmartPhone apps for mental health service delivery. The project is also timely as there is a temporary moratorium (imposed by the Office of Information Technology) on app dissemination within VHA, presenting an opportunity to study Moving Forward prior to its release. At the completion of this project, we expect that the work proposed in Aim 1 and 2 will highlight the clinical value of the Moving Forward app, which will inform both VA policy makers and the scientific community at large about the utility of SmartPhone technology in mental health care delivery. We also expect that Aim 3 will provide our partners at MHS with helpful feedback on the Moving Forward app design and future app development.
描述(由申请人提供): 退伍军人获得和参与循证心理治疗是退伍军人健康管理局(VHA)的高度优先事项,特别是农村健康办公室(ORH)和精神健康服务办公室(MHS)。智能手机应用是一项新兴技术,通过增加对提供者和自我管理工具的数字访问,具有巨大的潜力来扩大传统面对面心理治疗的覆盖范围。由于这项技术的发展相对较新,目前还没有关于智能手机提供的心理治疗效果的数据。关于可接受性和满意度的初步数据令人振奋,表明需要进一步研究。国家创伤后应激障碍中心与国家远程健康与技术中心(T2)合作,最近完成了一款名为Moving Forward的应用程序的开发,这是一种适用于老兵的问题解决疗法(PST),是一种通过初级保健综合诊所(PC-MHI)提供的循证疗法。与卫生部合作,这一拟议的试点项目将收集关于推进的有效性和可接受性的初步数据,并向应用程序创建者提供及时的反馈。参与者将包括40名被诊断患有焦虑或情绪障碍的退伍军人,他们有兴趣在PC-MHI获得心理健康治疗。参与者将被随机分配到6个PST会议,要么是由前移应用程序增强的PST,要么是单独的6个PST会议。参与者将在基线、6周和12周完成评估。我们提出了3个具体的假设。在假设1中,我们预测,与随机接受PST的患者相比,在6周和12周时,随机接受PST加前进APP的患者在PSSU(家庭作业完成)和CSQ8(满意度)上的得分将观察到效果大小e 0.3。在假设2中,我们预测,与随机使用PST的患者相比,在6周和12周时,随机使用PST加向前APP的患者在SPSI(问题解决风格)上的变化分数将观察到e 0.3。在假设3中,我们预测,与随机接受PST的患者相比,在6周和12周时,随机接受PST加前进APP的患者在DASS综合评分(抑郁、焦虑和压力)和SF-12(健康相关生活质量)上的变化分数时,将观察到效应大小e 0.3。关键线人访谈将提供关于前进应用程序的定性反馈,我们将与MHS的合作伙伴分享这些反馈。拟议的项目对于退伍军人特派团改善所有退伍军人,特别是那些在参与传统面对面治疗方面面临障碍的退伍军人来说很重要。这项拟议的研究涉及研究与发展办公室(Access)的三个主要重点领域之一、HSR&D的两个研究重点(Access/农村健康和精神健康)以及新关部长为21世纪提出的三项转型举措,其中包括:1)获得医疗服务,2)精神健康,3)以患者为中心。这项拟议的工作是创新的,因为它侧重于一种快速崛起的移动技术,该技术具有改善提供精神健康服务的机会和参与度的巨大潜力。到目前为止,还没有检查智能手机应用程序提供心理健康服务的随机有效性试验。该项目也是及时的,因为VHA内的应用程序传播暂时暂停(由信息技术办公室实施),这为在其发布之前研究向前发展提供了机会。在这个项目完成后,我们预计目标1和目标2中提议的工作将突出前进应用程序的临床价值,该应用程序将向退伍军人事务部政策制定者和广大科学界通报智能手机技术在精神卫生保健提供方面的应用。我们还期待Aim 3将为我们在MHS的合作伙伴提供关于推进应用程序设计和未来应用程序开发的有用反馈。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kathleen M Grubbs其他文献

Kathleen M Grubbs的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
  • 批准号:
    10109165
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Launchpad
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
肯尼亚艾滋病毒感染妇女围产期情绪和焦虑障碍的分级护理一体化
  • 批准号:
    10677075
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Understanding the Effects of Adolescent Nicotine Exposure on Increased Risk for Mood and Anxiety Disorders: Bridging the Gap from Pre-Clinical to Clinical Investigations
了解青少年尼古丁暴露对情绪和焦虑障碍风险增加的影响:弥合临床前研究与临床研究之间的差距
  • 批准号:
    478121
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Addressing perinatal mood and anxiety disorders (PMADs) through a doula intervention
通过导乐干预解决围产期情绪和焦虑障碍 (PMAD)
  • 批准号:
    10861961
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Evaluation of the effectiveness and implementation of online group cognitive behavioral therapy for perinatal women with anxiety disorders.
评估在线团体认知行为治疗对患有焦虑症的围产期妇女的有效性和实施情况。
  • 批准号:
    22KJ3164
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Investigating the error-related negativity and the balance N1 in children with anxiety disorders
调查焦虑症儿童的错误相关消极性和平衡 N1
  • 批准号:
    10685283
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
RESONY: Digital therapeutic to manage anxiety disorders
RESONY:管理焦虑症的数字疗法
  • 批准号:
    10042996
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant for R&D
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
  • 批准号:
    10705005
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Developing an adjunctive mobile application for co-morbid substance use and anxiety disorders: comprehensive user experience testing of the Unwinding Anxiety application
开发针对共病药物使用和焦虑症的辅助移动应用程序:Unwinding Anxiety 应用程序的综合用户体验测试
  • 批准号:
    10597521
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Investigating the role of neuroinflammation in environmental exposure-induced anxiety disorders
研究神经炎症在环境暴露诱发的焦虑症中的作用
  • 批准号:
    10573948
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了